Clinicopathological and prognostic value of lncRNA TPT1-AS1 in cancer: A systematic review study and meta-analysis.
暂无分享,去创建一个
Roshanak Shams | M. Alan | H. Rastad | Zeinab Khodaparast | M. Hashemnejad | M. Farahani | P. Samimisedeh | Mohammad Hossein Mozafary Bazargany | S. Moghadam
[1] G. Wang,et al. Positive feedback regulation of lncRNA TPT1‐AS1 and ITGB3 promotes cell growth and metastasis in pancreatic cancer , 2022, Cancer science.
[2] Q. Mo,et al. Long Non-coding RNA TPT1-AS1 Suppresses APC Transcription in a STAT1-Dependent Manner to Increase the Stemness of Colorectal Cancer Stem Cells , 2022, Molecular Biotechnology.
[3] Jinhua Dong,et al. Advances in the application of Let-7 microRNAs in the diagnosis, treatment and prognosis of leukemia , 2021, Oncology letters.
[4] Wei Wei,et al. Overexpression of IncRNA TPT1-AS1 Suppresses Hepatocellular Carcinoma Cell Proliferation by Downregulating CDK2. , 2022, Critical reviews in eukaryotic gene expression.
[5] Hao Li,et al. lncRNA TPT1-AS1 knockdown inhibits liver cancer cell proliferation, migration and invasion , 2021, Molecular medicine reports.
[6] Zhi Huang,et al. Immune-Related lncRNAs to Construct Novel Signatures and Predict the Prognosis of Rectal Cancer , 2021, Frontiers in Oncology.
[7] F. Bray,et al. The ever‐increasing importance of cancer as a leading cause of premature death worldwide , 2021, Cancer.
[8] A. Jemal,et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.
[9] Fei Ye,et al. Long noncoding RNA TPT1-AS1 promotes the progression and metastasis of colorectal cancer by upregulating the TPT1-mediated FAK and JAK-STAT3 signalling pathways , 2021, Aging.
[10] Subash C. Gupta,et al. Diagnostic, prognostic, and therapeutic significance of long non-coding RNA MALAT1 in cancer. , 2021, Biochimica et biophysica acta. Reviews on cancer.
[11] I. Santin,et al. The Role of lncRNAs in Gene Expression Regulation through mRNA Stabilization , 2021, Non-coding RNA.
[12] Zhaoyuan Fang,et al. QKI-5 regulates the alternative splicing of cytoskeletal gene ADD3 in lung cancer , 2020, Journal of molecular cell biology.
[13] Lihua Li,et al. Dyregulation of the lncRNA TPT1-AS1 positively regulates QKI expression and predicts a poor prognosis for patients with breast cancer. , 2020, Pathology, research and practice.
[14] Yang Cao,et al. LncRNA TPT1-AS1 Sponges miR-23a-5p in Glioblastoma to Promote Cancer Cell Proliferation. , 2020, Cancer biotherapy & radiopharmaceuticals.
[15] H. Ghaedi,et al. An updated review of the H19 lncRNA in human cancer: molecular mechanism and diagnostic and therapeutic importance , 2020, Molecular Biology Reports.
[16] Gang Xu,et al. High BANCR expression is associated with worse prognosis in human malignant carcinomas: an updated systematic review and meta-analysis , 2020, BMC cancer.
[17] Yushui Ma,et al. Targeting Long Non-coding RNA to Therapeutically Regulate Gene Expression in Cancer , 2020, Molecular therapy. Nucleic acids.
[18] A. Lin,et al. Discovering and validating cancer genetic dependencies: approaches and pitfalls , 2020, Nature Reviews Genetics.
[19] J. Xia,et al. miRNet 2.0: network-based visual analytics for miRNA functional analysis and systems biology , 2020, Nucleic Acids Res..
[20] Hao Liu,et al. Mechanisms of Long Non-Coding RNAs in Cancers and Their Dynamic Regulations , 2020, Cancers.
[21] Y. Qi,et al. Long non-coding RNA TPT1-AS1 promotes angiogenesis and metastasis of colorectal cancer through TPT1-AS1/NF90/VEGFA signaling pathway , 2020, Aging.
[22] H. Mozdarani,et al. The emerging role of the long non-coding RNA HOTAIR in breast cancer development and treatment , 2020, Journal of Translational Medicine.
[23] Zhihong Li,et al. Knockdown of TPT1-AS1 inhibits cell proliferation, cell cycle G1/S transition, and epithelial–mesenchymal transition in gastric cancer , 2020, Bosnian journal of basic medical sciences.
[24] Ssang-Goo Cho,et al. Understanding the Role of the Transcription Factor Sp1 in Ovarian Cancer: from Theory to Practice , 2020, International journal of molecular sciences.
[25] Yunbao Pan,et al. Emerging roles of HOTAIR in human cancer , 2020, Journal of cellular biochemistry.
[26] Jiabin Tang,et al. Long noncoding RNA TPT1‐AS1 downregulates the microRNA‐770‐5p expression to inhibit glioma cell autophagy and promote proliferation through STMN1 upregulation , 2020, Journal of cellular physiology.
[27] Eun Ju Kim,et al. QKI, a miR‐200 target gene, suppresses epithelial‐to‐mesenchymal transition and tumor growth , 2019, International journal of cancer.
[28] W. Zhuo,et al. Emerging roles of lncRNA in cancer and therapeutic opportunities. , 2019, American journal of cancer research.
[29] Yong Zhu,et al. LncRNA TPT1‐AS1 promotes tumorigenesis and metastasis in epithelial ovarian cancer by inducing TPT1 expression , 2019, Cancer science.
[30] Dan Zhang,et al. Association of STMN1 with survival in solid tumors: A systematic review and meta-analysis , 2019, The International journal of biological markers.
[31] Xiang-Yang Zan,et al. Construction of lncRNA-mediated ceRNA network to reveal clinically relevant lncRNA biomarkers in glioblastomas , 2019, Oncology letters.
[32] L. Floeter-Winter,et al. Long Non-Coding RNAs in the Regulation of Gene Expression: Physiology and Disease , 2019, Non-coding RNA.
[33] Li Ma,et al. New Insights into Long Non-Coding RNA MALAT1 in Cancer and Metastasis , 2019, Cancers.
[34] K. Polyak,et al. Insights into Molecular Classifications of Triple-Negative Breast Cancer: Improving Patient Selection for Treatment. , 2019, Cancer discovery.
[35] Jia Liu,et al. Potential clinical application of lncRNAs in non-small cell lung cancer , 2018, OncoTargets and therapy.
[36] Chern Ein Oon,et al. Molecular targeted therapy: Treating cancer with specificity , 2018, European journal of pharmacology.
[37] Guanqun Huang,et al. Long non-coding RNA TPT1-AS1 promotes cell growth and metastasis in cervical cancer via acting AS a sponge for miR-324-5p , 2018, Journal of Experimental & Clinical Cancer Research.
[38] T. Ochiya,et al. Emerging roles of long non‐coding RNA in cancer , 2018, Cancer science.
[39] D. Beer,et al. Silencing of Long Noncoding RNA MIR22HG Triggers Cell Survival/Death Signaling via Oncogenes YBX1, MET, and p21 in Lung Cancer. , 2018, Cancer research.
[40] Robert A. Weinberg,et al. EMT in cancer , 2018, Nature Reviews Cancer.
[41] I. Ng,et al. Non-coding RNAs in hepatocellular carcinoma: molecular functions and pathological implications , 2018, Nature Reviews Gastroenterology & Hepatology.
[42] Qihong Huang,et al. Long non-coding RNAs in metastasis , 2017, Cancer and Metastasis Reviews.
[43] Jie Hong,et al. Differentially Expressed lncRNAs in Gastric Cancer Patients: A Potential Biomarker for Gastric Cancer Prognosis , 2017, Journal of Cancer.
[44] Jing Tian,et al. lncRNA MALAT1, HOTTIP and PVT1 as predictors for predicting the efficacy of GEM based chemotherapy in first-line treatment of pancreatic cancer patients. , 2017, Oncotarget.
[45] K. Ligon,et al. Glioblastoma targeted therapy: updated approaches from recent biological insights , 2017, Annals of oncology : official journal of the European Society for Medical Oncology.
[46] Robert J. Lonigro,et al. Integrative Clinical Genomics of Metastatic Cancer , 2017, Nature.
[47] R. Goyal,et al. LncRNA as a Therapeutic Target for Angiogenesis , 2017, Current topics in medicinal chemistry.
[48] S. Cai,et al. Up-regulation of long non-coding RNA XLOC_010235 regulates epithelial-to-mesenchymal transition to promote metastasis by associating with Snail1 in gastric cancer , 2017, Scientific Reports.
[49] Carlo M. Croce,et al. Small non-coding RNA and cancer , 2017, Carcinogenesis.
[50] T. Rajkumar,et al. Perspectives of long non-coding RNAs in cancer , 2017, Molecular Biology Reports.
[51] Yuchen Liu,et al. Long noncoding RNA HOTTIP as a novel predictor of lymph node metastasis and survival in human cancer: a systematic review and meta-analysis , 2016, Oncotarget.
[52] Q. Lan,et al. LncRNA profile study reveals four-lncRNA signature associated with the prognosis of patients with anaplastic gliomas , 2016, Oncotarget.
[53] Shu Yang,et al. Identification of androgen-responsive lncRNAs as diagnostic and prognostic markers for prostate cancer , 2016, Oncotarget.
[54] Kai Wang,et al. Regulation of lncRNA and Its Role in Cancer Metastasis , 2016, Oncology research.
[55] Maite Huarte. The emerging role of lncRNAs in cancer , 2015, Nature Medicine.
[56] O. Khorkova,et al. Basic biology and therapeutic implications of lncRNA. , 2015, Advanced drug delivery reviews.
[57] J. Azizkhan-Clifford,et al. Sp1 and the ‘hallmarks of cancer’ , 2015, The FEBS journal.
[58] Guodong Yang,et al. LncRNA: a link between RNA and cancer. , 2014, Biochimica et biophysica acta.
[59] A. Alizadeh,et al. Metastasis review: from bench to bedside , 2014, Tumor Biology.
[60] Hui Zhou,et al. starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein–RNA interaction networks from large-scale CLIP-Seq data , 2013, Nucleic Acids Res..
[61] Denise P Barlow,et al. Gene regulation by the act of long non-coding RNA transcription , 2013, BMC Biology.
[62] Jianyong Sun,et al. Downregulation of tumor suppressor QKI in gastric cancer and its implication in cancer prognosis. , 2012, Biochemical and biophysical research communications.
[63] A. Puisieux,et al. Metastasis: a question of life or death , 2006, Nature Reviews Cancer.
[64] A. Pardee,et al. Analysing differential gene expression in cancer , 2003, Nature Reviews Cancer.